Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis

BMJ Case Reports - Tập 13 Số 7 - Trang e236815 - 2020
Florent Artru1, Lorenzo Alberio2, Darius Moradpour1, G. Stalder2
1Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
2Service and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Tóm tắt

We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reasonable to evoke ITP in case of profound thrombocytopaenia in a patient with COVID-19.

Từ khóa


Tài liệu tham khảo

Zulfiqar, 2020, Immune thrombocytopenic purpura in a patient with Covid-19, N Engl J Med, 382, e43, 10.1056/NEJMc2010472

Galeotti, 2020, Autoimmune and inflammatory diseases following COVID-19, Nat Rev Rheumatol, 10.1038/s41584-020-0448-7

Connors, 2020, COVID-19 and its implications for thrombosis and anticoagulation, Blood, 135, 2033, 10.1182/blood.2020006000

Cooper, 2019, Immune thrombocytopenia, N Engl J Med, 381, 945, 10.1056/NEJMcp1810479

10.1016/S0140-6736(20)30628-0

Singh, 2020, Clinical characteristics and outcomes of COVID-19 among patients with pre-existing liver disease in United States: a multi-center research network study, Gastroenterology

Thông tin
Thông tin xuất bản

BMJ Case Reports

Tập 13 Số 7

e236815

Thông tin tác giả